Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
9862 | 1114 | 48.6 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
230 | 3 | P GLYCOPROTEIN//FMO3//TRIMETHYLAMINURIA | 49374 |
747 | 2 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//MDR1 | 12474 |
9862 | 1 | P GLYCOPROTEIN//PHARMACORESISTANCE//TARIQUIDAR | 1114 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | P GLYCOPROTEIN | authKW | 784462 | 36% | 7% | 396 |
2 | PHARMACORESISTANCE | authKW | 645133 | 6% | 37% | 64 |
3 | TARIQUIDAR | authKW | 548159 | 3% | 67% | 30 |
4 | PHARMACOL TOXICOL PHARM | address | 463607 | 9% | 17% | 100 |
5 | C 11VERAPAMIL | authKW | 438544 | 1% | 100% | 16 |
6 | R C 11VERAPAMIL | authKW | 416901 | 2% | 89% | 17 |
7 | BLOOD BRAIN BARRIER | authKW | 391125 | 30% | 4% | 339 |
8 | MULTIDRUG TRANSPORTER | authKW | 341143 | 3% | 33% | 38 |
9 | C 11TARIQUIDAR | authKW | 164454 | 1% | 100% | 6 |
10 | BREAST CANCER RESISTANCE PROTEIN | authKW | 154669 | 3% | 16% | 35 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 3927 | 36% | 0% | 396 |
2 | Clinical Neurology | 2517 | 22% | 0% | 241 |
3 | Neurosciences | 2273 | 28% | 0% | 308 |
4 | Chemistry, Medicinal | 308 | 6% | 0% | 63 |
5 | Radiology, Nuclear Medicine & Medical Imaging | 233 | 7% | 0% | 76 |
6 | Medicine, Research & Experimental | 118 | 5% | 0% | 56 |
7 | Biochemistry & Molecular Biology | 40 | 10% | 0% | 111 |
8 | Endocrinology & Metabolism | 12 | 3% | 0% | 29 |
9 | Neuroimaging | 11 | 1% | 0% | 6 |
10 | Geriatrics & Gerontology | 11 | 1% | 0% | 9 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACOL TOXICOL PHARM | 463607 | 9% | 17% | 100 |
2 | BIOFORDRUG SRL | 122089 | 1% | 64% | 7 |
3 | PROBE SECTINAGE KU | 82227 | 0% | 100% | 3 |
4 | UNITE NEURO PHARMACO NUTR | 82227 | 0% | 100% | 3 |
5 | MEMBRANE TRANSPORT DRUG TARGETING | 56364 | 1% | 17% | 12 |
6 | AAB BIOMED SCI NEUROVASC BIOL | 54818 | 0% | 100% | 2 |
7 | CELL BIOL NEUROBIOL DR E DE ROBERTIS | 54818 | 0% | 100% | 2 |
8 | EPILEPSY UNITSECT CLIN PHARMACOL STROKE MED | 54818 | 0% | 100% | 2 |
9 | MOL PROBE | 48723 | 0% | 44% | 4 |
10 | EA 2706 | 38061 | 0% | 28% | 5 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EPILEPSIA | 12154 | 6% | 1% | 63 |
2 | PHARMACOGENOMICS | 11242 | 2% | 2% | 27 |
3 | EPILEPSY RESEARCH | 7208 | 3% | 1% | 32 |
4 | NUCLEAR MEDICINE AND BIOLOGY | 2949 | 2% | 1% | 20 |
5 | PHARMACOGENETICS AND GENOMICS | 2905 | 1% | 1% | 11 |
6 | EJNMMI RESEARCH | 2241 | 1% | 1% | 6 |
7 | JOURNAL OF NUCLEAR MEDICINE | 2074 | 3% | 0% | 28 |
8 | JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM | 2025 | 2% | 0% | 20 |
9 | CURRENT PHARMACEUTICAL DESIGN | 1740 | 2% | 0% | 20 |
10 | SEIZURE-EUROPEAN JOURNAL OF EPILEPSY | 1605 | 1% | 0% | 12 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | P GLYCOPROTEIN | 784462 | 36% | 7% | 396 | Search P+GLYCOPROTEIN | Search P+GLYCOPROTEIN |
2 | PHARMACORESISTANCE | 645133 | 6% | 37% | 64 | Search PHARMACORESISTANCE | Search PHARMACORESISTANCE |
3 | TARIQUIDAR | 548159 | 3% | 67% | 30 | Search TARIQUIDAR | Search TARIQUIDAR |
4 | C 11VERAPAMIL | 438544 | 1% | 100% | 16 | Search C+11VERAPAMIL | Search C+11VERAPAMIL |
5 | R C 11VERAPAMIL | 416901 | 2% | 89% | 17 | Search R+C+11VERAPAMIL | Search R+C+11VERAPAMIL |
6 | BLOOD BRAIN BARRIER | 391125 | 30% | 4% | 339 | Search BLOOD+BRAIN+BARRIER | Search BLOOD+BRAIN+BARRIER |
7 | MULTIDRUG TRANSPORTER | 341143 | 3% | 33% | 38 | Search MULTIDRUG+TRANSPORTER | Search MULTIDRUG+TRANSPORTER |
8 | C 11TARIQUIDAR | 164454 | 1% | 100% | 6 | Search C+11TARIQUIDAR | Search C+11TARIQUIDAR |
9 | BREAST CANCER RESISTANCE PROTEIN | 154669 | 3% | 16% | 35 | Search BREAST+CANCER+RESISTANCE+PROTEIN | Search BREAST+CANCER+RESISTANCE+PROTEIN |
10 | ABCB1 | 150984 | 5% | 9% | 61 | Search ABCB1 | Search ABCB1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | FELDMANN, M , KOEPP, M , (2016) ABC TRANSPORTERS AND DRUG RESISTANCE IN PATIENTS WITH EPILEPSY.CURRENT PHARMACEUTICAL DESIGN. VOL. 22. ISSUE 38. P. 5793 -5807 | 101 | 63% | 0 |
2 | ARONICA, E , SISODIYA, SM , GORTER, JA , (2012) CEREBRAL EXPRESSION OF DRUG TRANSPORTERS IN EPILEPSY.ADVANCED DRUG DELIVERY REVIEWS. VOL. 64. ISSUE 10. P. 919 -929 | 99 | 56% | 37 |
3 | QOSA, H , MILLER, DS , PASINELLI, P , TROTTI, D , (2015) REGULATION OF ABC EFFLUX TRANSPORTERS AT BLOOD-BRAIN BARRIER IN HEALTH AND NEUROLOGICAL DISORDERS.BRAIN RESEARCH. VOL. 1628. ISSUE . P. 298 -316 | 95 | 50% | 11 |
4 | ZHANG, CB , KWAN, P , ZUO, Z , BAUM, L , (2012) THE TRANSPORT OF ANTIEPILEPTIC DRUGS BY P-GLYCOPROTEIN.ADVANCED DRUG DELIVERY REVIEWS. VOL. 64. ISSUE 10. P. 930-942 | 77 | 63% | 50 |
5 | POTSCHKA, H , (2010) TRANSPORTER HYPOTHESIS OF DRUG-RESISTANT EPILEPSY: CHALLENGES FOR PHARMACOGENETIC APPROACHES.PHARMACOGENOMICS. VOL. 11. ISSUE 10. P. 1427-1438 | 66 | 90% | 9 |
6 | CHOUCHI, M , KAABACHI, W , KLAA, H , TIZAOUI, K , TURKI, IBY , HILA, L , (2017) RELATIONSHIP BETWEEN ABCB1 3435TT GENOTYPE AND ANTIEPILEPTIC DRUGS RESISTANCE IN EPILEPSY: UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS.BMC NEUROLOGY. VOL. 17. ISSUE . P. 1 -14 | 70 | 74% | 0 |
7 | POTSCHKA, H , LUNA-MUNGUIA, H , (2014) CNS TRANSPORTERS AND DRUG DELIVERY IN EPILEPSY.CURRENT PHARMACEUTICAL DESIGN. VOL. 20. ISSUE 10. P. 1534-1542 | 67 | 76% | 7 |
8 | SYVANEN, S , ERIKSSON, J , (2013) ADVANCES IN PET IMAGING OF P-GLYCOPROTEIN FUNCTION AT THE BLOOD-BRAIN BARRIER.ACS CHEMICAL NEUROSCIENCE. VOL. 4. ISSUE 2. P. 225-237 | 69 | 68% | 19 |
9 | HARTZ, AMS , BAUER, B , (2011) ABC TRANSPORTERS IN THE CNS - AN INVENTORY.CURRENT PHARMACEUTICAL BIOTECHNOLOGY. VOL. 12. ISSUE 4. P. 656-673 | 97 | 43% | 33 |
10 | LOSCHER, W , LUNA-TORTOS, C , ROMERMANN, K , FEDROWITZ, M , (2011) DO ATP-BINDING CASSETTE TRANSPORTERS CAUSE PHARMACORESISTANCE IN EPILEPSY? PROBLEMS AND APPROACHES IN DETERMINING WHICH ANTIEPILEPTIC DRUGS ARE AFFECTED.CURRENT PHARMACEUTICAL DESIGN. VOL. 17. ISSUE 26. P. 2808-2828 | 70 | 57% | 40 |
Classes with closest relation at Level 1 |